Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.283,10
-1,64%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Moderna Inc (MRNA) Moderna Inc (MRNA) Notizie

Moderna Inc

MRNA
112,23
1,92 (1,74%)
02 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/4/202413:28IHMARKETNEWSCoca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple..
10/4/202413:13IHMARKETNEWSDelta Generates US$37 Million Profit in Q1, Google and Intel..
11/3/202421:08EDGAR2Form PRE 14A - Other preliminary proxy statements
11/3/202414:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202421:22EDGAR2Form 144 - Report of proposed sale of securities
06/3/202421:13EDGAR2Form 144 - Report of proposed sale of securities
05/3/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202421:32EDGAR2Form 144 - Report of proposed sale of securities
04/3/202421:25EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:28EDGAR2Form 144 - Report of proposed sale of securities
29/2/202422:49EDGAR2Form 144 - Report of proposed sale of securities
29/2/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:24EDGAR2Form 144 - Report of proposed sale of securities
29/2/202422:15EDGAR2Form 144 - Report of proposed sale of securities
27/2/202415:14IHMARKETNEWSU.S. Stocks May Lack Direction Following Yesterday’s Modest..
23/2/202422:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/2/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202421:39EDGAR2Form 144 - Report of proposed sale of securities
22/2/202412:32EDGAR2Form 8-K - Current report
22/2/202412:05IHMARKETNEWSU.S. Futures Surge on Nvidia’s Stellar Performance, Global..
16/2/202422:20EDGAR2Form 144 - Report of proposed sale of securities
16/2/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202401:07APSThe Power of Execution: Why Investors Reward Companies Who..
13/2/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202421:39EDGAR2Form 144 - Report of proposed sale of securities
17/1/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202422:10EDGAR2Form 144 - Report of proposed sale of securities
09/1/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202412:12IHMARKETNEWSWall Street Highlights: HPE and Juniper Networks in..
08/1/202421:21EDGAR2Form 144 - Report of proposed sale of securities
08/1/202413:03EDGAR2Form 8-K - Current report
03/1/202411:41IHMARKETNEWSWall Street Highlights: Tesla’s Competition with BYD,..
28/12/202314:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202317:37EDGAR2Form 144 - Report of proposed sale of securities
14/12/202321:26DJNTrending: Moderna Shares Rise on Favorable Skin Cancer Study..
14/12/202313:00PRNUSFirst In Vivo CAR-M Lead Candidate Nominated Under..
13/12/202314:31DJNModerna Shares, Other Covid Vaccine Makers Hit by Warning..
13/12/202312:30IHMARKETNEWSCal-Maine Avian Flu Outbreak Impact, Amgen Hikes Dividend..
12/12/202314:04EDGAR2Form 8-K - Current report
11/12/202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202313:41DJNMerck, Moderna Expand Phase 3 Keytruda/V940 Combo Work
11/12/202312:45BWMerck and Moderna Initiate INTerpath-002, a Phase 3 Study..
08/12/202321:24EDGAR2Form 144 - Report of proposed sale of securities
07/12/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202313:00RNSNONModerna Inc Moderna Reviews Progress at ESG Investor Event
Apertura: 111,11 Min: 109,00 Max: 113,73
Chiusura: 110,31

La tua Cronologia

NASDAQ
MRNA
Moderna
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network